Why Are These Biotech Bigdogs Attracted To This Company?
The key to finding the best opportunities? Look at where some of the biggest names in the biotech industry going & what therapies are they looking to bring to market? Pay close attention to revenue opportunities that exist for these therapies. These revenue opportunities could make such industry leaders choose to join a specific company.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Presents Its Financial Results For The Fourth Quarter Of 2017
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has made public its financial results for the fourth quarter of the year ended December 31, 2017. From the look of things, the biopharmaceutical company has been doing well especially with its NUPLAZID. Despite the tight market competition, the treatment, which is primarily used in the treatment of Parkinson’s disease psychosis posted very positive growth.